Ajax-Loading

Merck & Company Inc - Diluted EPS

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD.

The item "Diluted-EPS" stands at 7.56 United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Merck & Company Inc's third quarter result of 2.32 USD for the item "Diluted EPS" represents an increase of 31.46 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 2.32 USD for the item "Diluted EPS" represents an increase of 86.40 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 7.56 USD for the item "Diluted EPS" represents an increase of 16.56 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 57.87 percent compared to the value the year prior.
The 1 year change in percent is 57.87.
The 3 year change in percent is 25.71.
The 5 year change in percent is 66.92.
The 10 year change in percent is 101.11.

The Serie's long term average value is 3.02 United States Dollars. It's latest available value, on 09/30/2025, is 149.92 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +5,446.20%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Diluted EPS for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Diluted EPS905,699,262,464.00
LogoJohnson & Johnson - Diluted EPS486,508,953,600.00
LogoAbbVie Inc - Diluted EPS399,570,305,024.00
LogoRoche Holding AG - Diluted EPS317,433,206,677.55
LogoAstraZeneca PLC - Diluted EPS280,205,508,085.11